Allergan plc. (NYSE:AGN) : Currently there are 11 street experts covering Allergan plc. (NYSE:AGN) stock. The most bullish and bearish price target for the stock is $400 and $232 respectively for the short term. The average price target of all the analysts comes to $294. The estimated standard deviation from the target is $51.46.
Other Equity analysts have also commented on the company shares. Major Brokerage house, Piper Jaffray downgrades its ratings on Allergan plc. (NYSE:AGN). In the latest research report, Piper Jaffray lowers the target price from $311 per share to $238 per share. According to the latest information available, the shares are now rated Neutral by the analysts at the agency. Previously, the analysts had a Overweight rating on the shares. The rating by the firm was issued on April 18, 2016.
Allergan plc. (NYSE:AGN): stock turned positive on Thursday. Though the stock opened at $230.94, the bulls momentum made the stock top out at $233.75 level for the day. The stock recorded a low of $228.07 and closed the trading day at $233.51, in the green by 2.17%. The total traded volume for the day was 2,745,614. The stock had closed at $228.55 in the previous days trading.
On the companys insider trading activities, Hilado Maria Teresa, CFO of Allergan Plc, had purchased 661 shares on June 2, 2016. The total value of the transaction was $159,678. The information was disclosed with the SEC in a Form 4 Filing. The information is based on open market trades at the market prices.Option exercises are not covered.